- Home
- FICO vs MIST Comparison
FICO vs MIST Comparison
Compare FICO & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FICO | MIST |
|---|---|---|
| Founded | 1956 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.3B | 136.9M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FICO | MIST |
|---|---|---|
| Price | $1,147.51 | $1.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $1,689.92 | $8.00 |
| AVG Volume (30 Days) | 383.8K | ★ 1.6M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.78 | N/A |
| EPS | ★ 28.12 | N/A |
| Revenue | ★ $1,032,475,000.00 | N/A |
| Revenue This Year | $27.28 | $2,915.14 |
| Revenue Next Year | $16.97 | N/A |
| P/E Ratio | $41.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $870.01 | $1.00 |
| 52 Week High | $1,998.01 | $3.06 |
Technical Indicators
Market Signals| Indicator | FICO | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 52.65 | 45.54 |
| Support Level | $1,067.18 | $1.01 |
| Resistance Level | $1,329.48 | $1.42 |
| Average True Range (ATR) | 48.29 | 0.07 |
| MACD | 9.68 | -0.00 |
| Stochastic Oscillator | 87.43 | 32.00 |
Price Performance
Historical ComparisonAbout FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.